The members of the Treatment Council appointed in Denmark

08

Mar 2021

The Treatment Council is a new model for assessing treatment methods and health technologies, expected to become fully operational in early 2021. Earlier in February 2021, the final method and process framework of the Treatment Council was approved. In late February 2021, eleven out of fifteen needed members and three observers of the Treatment Council (Behandlingsråd) were appointed in Denmark.

The Treatment Council should consist of representatives from the five regions, two health economists, two patient representatives, representatives from the professional environments and agencies, and a representative from the industry.

The chairman of the Treatment Council is appointed by the Danish Regions. The remaining members are assigned by the Regions, medical societies (LVS), the Danish Nurses' Organization (DASYS), "Danish Patients" (an umbrella organization for patients and related associations), Disabled Peoples' Organizations Denmark, the Danish Health Authority (Sundhedsstyrelsen), the Danish Medicines Agency, industry and the Council itself.

The first meeting of the Treatment Council is planned to be conducted in May 2021, and one of the first tasks will be to assign the remaining four members.

The full details in Danish can be found here. The list of actual Treatment Council members can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.

The latest related news

24

Mar 2022

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 2472 of February 10, 2022, Tuscany Regional Healthcare has published assessments of five medical devices of various therapeutic areas, such as cardiovascular and peripheral vascular areas.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more

11

Mar 2022

On February 07, 2022, the Dental and Pharmaceutical Benefits Agency has announced the withdrawal of the assessments of the PhysioMem PM 100 and CardioMem CM 100 XT and the finalization of the assessments of the Zenicor ECG, Coala Heart Monitor Pro, and KardiaMobile. For the conducted assessments, it was outlined that the portable devices provide more limited information than standard ECG measurements; therefore, it was mainly estimated for atrial fibrillation.

Read more

10

Mar 2022

In February 2022, the Finnish Coordinating Center for Health Technology Assessment announced the release of the seven accomplished rapid hospital assessments performed by the Helsinki, Tampere, and Oulu University Hospital. The accomplished rapid HTAs concern the diagnostic imaging, e-Health, endocrine, endoscopy, men’s health, neuromodulation technology groups.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more